Evaluation of the oxidation-nitrosyl stress manifestations at systematic connective tissue diseases

QR Code

Evaluation of the oxidation-nitrosyl stress manifestations at systematic connective tissue diseases

Reduction in antioxidant status with low activity of superoxide dismutase, glutathione peroxidase and glutathione reductase red blood cells at a low level of reduced glutathionein the background and increased NOx levels in blood plasmawas detected in patients with systematic connective tissue and jo...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. A. Alexandrova, N. A. Filippova, T. F. Subbotina, E. S. Alekseevskaya, A. A. Zhloba, V. I. Trofimov
Format:	Article
Language:	Russian
Published:	Academician I.P. Pavlov First St. Petersburg State Medical University 2016-03-01
Series:	Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова
Subjects:	rheumatoid arthritis ankylosing spondylitis glutathione nitric oxide antioxidant status
Online Access:	https://www.sci-notes.ru/jour/article/view/172
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE FIRST EXPERIENCE IN USING ADALIMUMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: CLINICAL AND MRICOMPARISONS OF THE RESULTS OF THERAPY
by: A G Bochkova, et al.
Published: (2010-02-01)

INTERRELATIONSHIP OF THE MEDIATOR OF ANGIOGENESIS OF VEGF-A WITH GLUTATHIONE METABOLISM PARAMETERS AND THE CLINICAL CHARACTERISTICS OF SYSTEMIC AUTOIMMUNE DISEASES WITH JOINT DAMAGE
by: L. A. Alexandrova, et al.
Published: (2019-04-01)

Combination of ankylosing spondylitis and rheumatoid arthritis: clinical observations and literature review
by: A. A. Godzenko, et al.
Published: (2021-08-01)

Etoricoxib – 15 years in Russia: the main results in the treatment of rheumatic diseases
by: N. V. Chichasova, et al.
Published: (2024-01-01)

Rheumatic manifestations of endocrine diseases: skeletal diseases in hypoparathyroidism
by: Viktoria Georgiyevna Barskova, et al.
Published: (2013-10-01)

SIGNIFICANCE OF PERIPHERAL ARTHRITIS IN ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes, et al.
Published: (2014-06-01)

Extraskeletal manifestations and the indicators of inflammatory activity and severity in ankylosing spondylitis
by: A. A. Godzenko, et al.
Published: (2018-04-01)

Effects of seed deterioration on physiological traits, antioxidant enzymes and S-nitrosylation of proteins in two cultivars of canola (Brassica napus L.)
by: Maryam Zamanian, et al.
Published: (2023-04-01)

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy
by: M. M. Baranova, et al.
Published: (2024-06-01)

Contribution of neurogenic mechanisms to the pathogenesis of chronic joint pain
by: E. S. Filatova, et al.
Published: (2021-04-01)

Disorder Activity of Some Enzymes Plays an Important Role in Pathological Mechanism of Rheumatoid Arthritis Disease
by: Baghdad Science Journal
Published: (2015-09-01)

Golimumab for Treating Chronic Inflammatory Joint Diseases in the Adult Population: Clinical Efficacy and Tolerability
by: Natal’ya N. Chichasova
Published: (2019-01-01)

ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
by: A E Karateev
Published: (2009-06-01)

CONSERVATIVE ORTHOPEDIC TREATMENT OF RHEUMATIC DISEASES: RHEUMATOID ARTHRITIS, ANKYLOSING SPONDYLITIS, OSTEOARTHROSIS, SOFT TISSUE DISEASES (PART II)
by: V P Pavlov
Published: (2009-06-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
by: Yu. V. Muravyev, et al.
Published: (2020-05-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
by: E. E. Gubar, et al.
Published: (2023-08-01)

IL-23/IL-17 INHIBITORS IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES: NEW HORIZONS
by: E. L. Nasonov, et al.
Published: (2019-09-01)

Diagnosis of spondyloarthritis: should we need new criteria?
by: I. Z. Gaidukova, et al.
Published: (2015-03-01)

COXITIS IN ANKYLOSING SPONDYLITIS: COMPARISON OF CLINICAL MANIFESTATIONS WITH ULTRASOUND STUDY DATA
by: M. V. Podryadnova, et al.
Published: (2014-09-01)

Influence of biologics on carbohydrate metabolism and risk of diabetes
by: L. V. Kondratieva, et al.
Published: (2019-05-01)

NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
by: E. L. Nasonov
Published: (2017-03-01)

SPONTANEOUS IMMUNOGLOBULIN-SYNTHESIZING ACTIVITY OF B LYMPHOCYTES IN INFLAMMATORY RHEUMATIC DISEASES
by: A.T. T. Mamasaidov, et al.
Published: (2014-07-01)

Golimumab therapy-induced indicators of X-ray inflammation progression and magnitude according to magnetic resonance imaging evidence in patients with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis
by: Aleksandr Viktorovich Smirnov
Published: (2013-06-01)

Comparative analysis of the functional status of hip joints before total hip replacement in patients with ankylosing spondylitis, rheumatoid arthritis and coxarthrosis: preliminary data of a retrospective study
by: A. O. Dubinin, et al.
Published: (2025-07-01)

«TREAT-TO-TARGET» (T2T) STRATEGY IN SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2014-06-01)

PROGRESSION AND OUTCOMES OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDILITIS
by: A. A. Godzenko, et al.
Published: (2014-10-01)

Impact of the trace element status on the course of ankylosing spondylitis in the Orenburg Region patients
by: U. A. Yakubova, et al.
Published: (2019-10-01)

PROJECT OF WORKING CLASSIFICATION OF ANKYLOSING SPONDILYTIS
by: Shandor F Erdes, et al.
Published: (2014-02-01)

Changing the concept of spondyloarthritis: Characteristics of teaching when changing the paradigm in a particular area of medical knowledge
by: I. Z. Gaydukova, et al.
Published: (2017-04-01)

Coxitis in patients with ankylosing spondylitis: clinicoradio logic comparisons
by: A. G. Bochkova, et al.
Published: (2005-08-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
by: T. V. Dubinina, et al.
Published: (2023-02-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

Evaluation of efficacy and safety of long-term use of amtolmetin guacil in rheumatic diseases: results of a 9-month observational AURORA study (Amtolmetin guacil: allRussian Register for Osteoarthritis, Rheumatoid arthritis and Ankylosing spondylitis)
by: A. E. Karateev, et al.
Published: (2019-03-01)

Osteophytes in the Joints of Patients with Ankylosing Spondylitis: Manifestation of Osteoarthritis or Underlying Disease?
by: K. D. Dorogoykina, et al.
Published: (2020-05-01)

New etanercept biosimilar — expanding treatment options for immune-mediated inflammatory rheumatic diseases
by: A. E. Karateev, et al.
Published: (2022-12-01)

OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

Clinical diversity of ankylosing spondylitis in the real practice of a rheumatologist in Russia (Part 1)
by: Evgeny Vladimirovich Volnukhin, et al.
Published: (2012-04-01)

COURSE OF UVEITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: A. A. Godzenko, et al.
Published: (2016-09-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
by: Tatyana Valentinovna Mezenova, et al.
Published: (2012-04-01)